The new beta-lactamases

Journal article

Peer reviewed

The New England journal of medicine, Vol.352(4), pp.380-391

2005-01-27

PMID: 15673804

Abstract

Anti-Bacterial Agents - pharmacology

Anti-Bacterial Agents - therapeutic use

beta-Lactam Resistance - genetics

beta-Lactam Resistance - physiology

beta-Lactamases - chemistry

beta-Lactamases - classification

beta-Lactamases - genetics

beta-Lactams - pharmacology

beta-Lactams - therapeutic use

Disease Outbreaks - prevention & control

Gram-Negative Bacteria - drug effects

Gram-Negative Bacteria - enzymology

Gram-Negative Bacterial Infections - drug therapy

Gram-Negative Bacterial Infections - epidemiology

Humans

Molecular Conformation

Risk Factors

20 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.23 Antibiotics & Antimicrobials; 1.23.146 Antibiotic Resistance
Web Of Science research areas: Microbiology
ESI research areas: Clinical Medicine

This output has contributed to the advancement of the following goals:

Source: InCites

Title: The new beta-lactamases
Creators: George A Jacoby - Department of Infectious Diseases, Lahey Clinic, Burlington, Mass 01805, USA. george.a.jacoby@lahey.org
Luisa Silvia Munoz-Price
Publication Details: The New England journal of medicine, Vol.352(4), pp.380-391
Academic Unit: Miller School of Medicine; UMMG Department of Public Health Sciences Research
Language: English
Resource Type: Journal article
PMID: 15673804
Record Identifier: 991031613354202976